Prof. Mechoulam 'mahaifin binciken cannabis' ya mutu

ƙofar Ƙungiyar Inc.

binciken shuka cannabis

Raphael Mechoulam, mahaifin binciken cannabis, ya mutu yana da shekaru 92. Masanin Isra'ila mai binciken ya taimaka fadada ilimin kimiyya game da cannabis da mahadi da ke haifar da sa hannun magungunan.

A cewar Abokan Amurka na Jami'ar Hebrew, Mechoulam, mai shekaru 92, ya mutu a Urushalima a farkon wannan watan. Ofaya daga cikin gudummawar Mechoulam ga karatun marijuana shine keɓewar farko na fili na psychoactive daga shuka cannabis - tetrahydrocannabinol (THC). Aikinsa ya sa aka yi masa laqabi da babansa binciken cannabis' na.
Shi “Majagaba ne mai hazaka kuma mai kwarjini,” in ji Asher Cohen, shugaban Jami’ar Ibrananci ta Urushalima, inda Mechoulam ya dade yana hidima a jami’ar.

Nazarin cannabis na majagaba

"Mafi yawan ilimin ɗan adam da kimiyya game da cannabis an tattara su ne godiya ga Farfesa Mechoulam. Ya ba da hanyar yin nazari mai zurfi tare da kafa haɗin gwiwar kimiyya tsakanin masu bincike a duniya," in ji Cohen. "Wannan rana ce ta bakin ciki ga al'ummar ilimi da jami'a." An haifi Mechoulam a shekara ta 1930 a Bulgaria. Ya yi hijira zuwa Isra'ila a shekara ta 1949 kuma ba da daɗewa ba ya sami horo a kan sinadarai. Lokacin da Mechoulam ya shiga fagen bincike a cikin XNUMXs, morphine da cocaine sun daɗe sun keɓe daga opium da coca.

Ba za a iya faɗi irin tabar wiwi, ko hashish ba. Don haka shi da tawagarsa masu bincike, sannan a Cibiyar Kimiyya ta Weizmann da ke Isra'ila, sun mai da hankalinsu ga shukar kore a shekarar 1962, a daidai lokacin da ta ke samun karbuwa a duniya.

A tsawon lokacin aikinsa, marijuana ya girma duka cikin shahara da kuma jayayya yayin da muhawara ta tashi kan amincinta. A cikin 1970, Amurka ta ayyana marijuana a matsayin "kayan sarrafawa". Mechoulam, wanda ya koma Jami'ar Hebrew ta Kudus a 1972, ya ci gaba da karatunsa na shekaru da yawa. Ya yi aiki a kan hanyoyin da za a ware da kuma haɗa sauran mahadi na shuka da kuma nuna yiwuwar amfani da shi a fannin likitanci. Misali don maganin farfadiya da cututtukan autoimmune. Har ila yau, aikinsa ya taimaka wajen nuna cewa, duk da takaddama game da amfani da shi a rabi na biyu na karni na 20, mutane sun yi amfani da tabar wiwi na dubban shekaru.

Source: npr.org (En)

Shafuka masu dangantaka

Bar sharhi

[banner = "89"]